NCT06092606 2023-10-23
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Phase 2 Unknown
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Newish Technology (Beijing) Co., Ltd.
The University of Hong Kong
Seoul National University Hospital
Chinese University of Hong Kong
Haukeland University Hospital
Zhejiang Cancer Hospital
Peking Union Medical College Hospital